Furthermore, an existing study has emphasized that luteolin can protect against diabetic cardiomyopathy via nuclear factor‐kappa B (NF‐κB) pathway‐mediated inflammation, along with the activation of antioxidant responses.21 The gene discussed is NFKB1; the disease is diabetic cardiomyopathy.